| Item | Value |
|---|---|
| DrugBank ID | DB14649 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | plasma cell myeloma | TxGNN Knowledge Graph |
| 2 | plasma cell myeloma | TxGNN Knowledge Graph |
| 3 | plasma cell myeloma | TxGNN Knowledge Graph |
| 4 | plasma cell myeloma | TxGNN Knowledge Graph |
| 5 | plasma cell myeloma | TxGNN Knowledge Graph |
| 6 | plasma cell myeloma | TxGNN Knowledge Graph |
| 7 | plasma cell myeloma | TxGNN Knowledge Graph |
| 8 | plasma cell myeloma | TxGNN Knowledge Graph |
| 9 | plasma cell myeloma | TxGNN Knowledge Graph |
| 10 | plasma cell myeloma | TxGNN Knowledge Graph |
| 11 | plasma cell myeloma | TxGNN Knowledge Graph |
| 12 | plasma cell myeloma | TxGNN Knowledge Graph |
| 13 | plasma cell myeloma | TxGNN Knowledge Graph |
| 14 | plasma cell myeloma | TxGNN Knowledge Graph |
| 15 | plasma cell myeloma | TxGNN Knowledge Graph |
| 16 | plasma cell myeloma | TxGNN Knowledge Graph |
| 17 | plasma cell myeloma | TxGNN Knowledge Graph |
| 18 | plasma cell myeloma | TxGNN Knowledge Graph |
| 19 | plasma cell myeloma | TxGNN Knowledge Graph |
| 20 | plasma cell myeloma | TxGNN Knowledge Graph |
| 21 | plasma cell myeloma | TxGNN Knowledge Graph |
| 22 | plasma cell myeloma | TxGNN Knowledge Graph |
| 23 | plasma cell myeloma | TxGNN Knowledge Graph |
| 24 | plasma cell myeloma | TxGNN Knowledge Graph |
| 25 | plasma cell myeloma | TxGNN Knowledge Graph |
| 26 | plasma cell myeloma | TxGNN Knowledge Graph |
| 27 | plasma cell myeloma | TxGNN Knowledge Graph |
| 28 | plasma cell myeloma | TxGNN Knowledge Graph |
| 29 | plasma cell myeloma | TxGNN Knowledge Graph |
| 30 | plasma cell myeloma | TxGNN Knowledge Graph |
| 31 | plasma cell myeloma | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.